Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeoScan Medical was a U.S. medical device company focused on image-guided urology tools, particularly MRI/ultrasound fusion technology for targeted prostate biopsy. The company is best known for BioJet, a 3D MRI/US prostate image fusion biopsy system designed to help physicians localize suspicious prostate lesions and guide biopsy procedures more accurately than conventional ultrasound-guided approaches. Published clinical literature and trade references describe BioJet as an FDA-cleared system used in prostate cancer diagnostic workflows. Available evidence indicates GeoScan Medical operated as a commercial-stage device company rather than a therapeutics developer, and there is limited recent evidence of ongoing standalone corporate activity. The company appears to have had a narrow product focus centered on fusion-guided prostate biopsy and related navigation software/hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeoScan Medical.